Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Masaya Ogasawara, Masahiro Takeshima, Shumpei Kosaka, Aya Imanishi, Yu Itoh, Dai Fujiwara, Kazuhisa Yoshizawa, Norio Ozaki, Kazuyuki Nakagome & Kazuo Mishima. (2023) Exploratory Validation of Sleep-Tracking Devices in Patients with Psychiatric Disorders. Nature and Science of Sleep 15, pages 301-312.
Read now
Read now
Felicia Forma, Joshua N. Liberman, Pinyao Rui & Charles Ruetsch. (2023) Adherence to augmentation therapy for the treatment of major depressive disorder. Expert Review of Pharmacoeconomics & Outcomes Research 23:3, pages 327-335.
Read now
Read now
Felicia Forma, Joshua N Liberman, Pinyao Rui, Emily Wiggins & Charles Ruetsch. (2022) Measuring Response to Adjunctive Therapy Among Individuals with Major Depressive Disorder. Neuropsychiatric Disease and Treatment 18, pages 2467-2475.
Read now
Read now
Articles from other publishers (20)
Jingjing Shi, Xiaohong Wang, Na Zhao, Chuanyi Kang, Liying Yang, Yue Zheng, Jiacheng Liu, Lei Feng, Xuequan Zhu, Caina Ma, Wenyuan Wu, Gang Wang & Jian Hu. (2023) Sex differences in residual somatic symptoms in patients with first-episode depression after acute-phase treatment. BMC Psychiatry 23:1.
Crossref
Crossref
Joshua Liberman, Jacqueline Pesa, Pinyao Rui, Kruti Joshi & Lisa Harding. (2023) Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder. Medicine 102:7, pages e32895.
Crossref
Crossref
Jarurin Pitanupong, Katti Sathaporn & Laddaporn Tepsuan. (2022) Residual symptoms and their associated factors among Thai patients with depression: a multihospital-based survey. Annals of General Psychiatry 21:1.
Crossref
Crossref
Akise Umakoshi, Masahiro Takeshima, Yu Itoh, Mari Yamamoto, Nana Shibata, Masaya Ogasawara, Naoko Ayabe & Kazuo Mishima. (2022)
Relationship among psychotic features, benzodiazepine receptor agonists, and rehospitalization in patients with electroconvulsive therapy‐responsive major depressive disorder: A retrospective
2‐year
observational study
. Neuropsychopharmacology Reports 42:4, pages 449-456.
Crossref
Crossref
Darawan Wongprommate, Tinakon Wongpakaran, Manee Pinyopornpanish, Peerasak Lerttrakarnnon, Surin Jiraniramai, Sirina Satthapisit, Nattha Saisavoey, Kamonporn Wannarit, Daochompu Nakawiro, Thanita Tantrarungroj & Nahathai Wongpakaran. (2021) Predictors for quality of life among older adults with depressive disorders: A prospective 3‐month follow‐up cohort study. Perspectives in Psychiatric Care 58:3, pages 1029-1036.
Crossref
Crossref
Charles Ruetsch, Joshua N. Liberman, Tigwa H. Davis, Martha Sajatovic, Dawn I. Velligan, Emily K. Wiggins & Felicia Forma. (2022) The effect of objectively collected medication adherence information on bipolar I and major depressive disorder treatment decisions: A randomized case vignette study of psychiatric clinicians. Journal of Affective Disorders Reports 9, pages 100344.
Crossref
Crossref
Li Chen, Shoumei Jia, Ping Li, Zhongying Shi & Yang Li. (2022) Experiences and coping strategies of somatic symptoms in patients with depressive disorder: A qualitative study. Archives of Psychiatric Nursing 38, pages 6-13.
Crossref
Crossref
Zhu-Qing Zhang, Ming-Hao Yang, Zhi-Peng Guo, Dan Liao, Peter Sörös, Meng Li, Martin Walter, Lihong Wang & Chun-Hong Liu. (2022) Increased prefrontal cortex connectivity associated with depression vulnerability and relapse. Journal of Affective Disorders 304, pages 133-141.
Crossref
Crossref
Ching‐I Hung, Chia‐Yih Liu, Shih‐Chieh Hsu & Ching‐Hui Yang. (2021) Comparing the associations of three psychometric scales at baseline with long‐term prognosis of depression over a 10‐year period. International Journal of Methods in Psychiatric Research 31:1.
Crossref
Crossref
N.N. Petrova. (2022) New goals for depression therapy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 122:11, pages 57.
Crossref
Crossref
Kentaro Yamato, Ken Inada, Minori Enomoto, Tatsuro Marumoto, Masahiro Takeshima & Kazuo Mishima. (2021) Patterns of hypnotic prescribing for residual insomnia and recurrence of major depressive disorder: a retrospective cohort study using a Japanese health insurance claims database. BMC Psychiatry 21:1.
Crossref
Crossref
Hehua Li, Yuanyuan Huang, Xiaocui Zang, Zhimin Zhu, Mingzhe Yang, Xiao E Lang, Kai Wu, Fengchun Wu & Xiang Yang Zhang. (2021) The relationship between overweight and thyroid function in first-episode, untreated Chinese patients with major depressive disorder with different ages of onset. Journal of Affective Disorders 294, pages 932-938.
Crossref
Crossref
Cheolmin Shin, Chi-Un Pae, Kyung Phil Kwak, Sang Won Jeon, Hyun-Ghang Jeong, Jong-Woo Kim, Youn Jung Lee, Ashwin A. Patkar & Changsu Han. (2021) Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder. Clinical Psychopharmacology and Neuroscience 19:2, pages 243-253.
Crossref
Crossref
Ken Inada, Minori Enomoto, Kentaro Yamato, Tatsuro Marumoto, Masahiro Takeshima & Kazuo Mishima. (2021) Effect of residual insomnia and use of hypnotics on relapse of depression: a retrospective cohort study using a health insurance claims database. Journal of Affective Disorders 281, pages 539-546.
Crossref
Crossref
Zhenzhen Wang, Haitao Qu, Jiaqi Zhong, Yang Han, Cheng Wan, Hui Wang, Hua Yang, Shuhong Lu, Kaili Diao, Ning Zhang & Hui Ma. (2020) Restoration of psychosocial functioning in remitted major depressive disorder patients: A 1-year longitudinal study. Comprehensive Psychiatry 102, pages 152204.
Crossref
Crossref
Joshua N. LibermanTigwa DavisJacqui PesaWing ChowJohn VerbanacSara Heverly-FittCharles Ruetsch. (2020) Predicting Incident Treatment-Resistant Depression: A Model Designed for Health Systems of Care. Journal of Managed Care & Specialty Pharmacy 26:8, pages 987-995.
Crossref
Crossref
Le Xiao, Jing-jing Zhou, Yuan Feng, Xue-quan Zhu, Wen-yuan Wu, Yong-dong Hu, Ya-juan Niu, Jian Hu, Xue-yi Wang, Cheng-ge Gao, Ning Zhang, Yi-ru Fang, Tie-bang Liu, Fu-jun Jia, Lei Feng & Gang Wang. (2020) Does early and late life depression differ in residual symptoms, functioning and quality of life among the first-episode major depressive patients. Asian Journal of Psychiatry 47, pages 101843.
Crossref
Crossref
Ruei-An Chen, Chun-Yi Lee, Yu Lee, Chi-Fa Hung, Yu-Chi Huang, Pao-Yen Lin, Sheng-Yu Lee & Liang-Jen Wang. (2019) Defining cognitive profiles of depressive patients using the Brief Assessment of Cognition in Affective Disorders. PeerJ 7, pages e7432.
Crossref
Crossref
Carol C. Choo, Peter K. H. Chew, Cyrus S. Ho & Roger C. Ho. (2019) Quality of Life in Patients With a Major Mental Disorder in Singapore. Frontiers in Psychiatry 9.
Crossref
Crossref
Na Zhao, Xiaohong Wang, Wenyuan Wu, Yongdong Hu, Yajuan Niu, Xueyi Wang, Chengge Gao, Ning Zhang, Yiru Fang, Jizhong Huang, Tiebang Liu, Fujun Jia, Xuequan Zhu, Jian Hu & Gang Wang. (2017) Gender differences in quality of life and functional disability for depression outpatients with or without residual symptoms after acute phase treatment in China. Journal of Affective Disorders 219, pages 141-148.
Crossref
Crossref